We are live on ! Find out more
HWAM

Hennion & Walsh Asset Management Portfolio holdings

AUM $3.5B
1-Year Est. Return 41.95%
This Fund
S&P 500
This Quarter Est. Return
-3.18%
1 Year Est. Return
+41.95%
3 Year Est. Return
+93.92%
5 Year Est. Return
+100.55%
10 Year Est. Return
AUM
$1.57B
AUM Growth
-$118M
Cap. Flow
-$42.5M
Cap. Flow %
-2.71%
Top 10 Hldgs %
17.86%
Holding
854
New
57
Increased
321
Reduced
405
Closed
55
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MTB icon
351
M&T Bank
MTB
$36.4B
$1.03M 0.07%
8,161
-2,888
-26% -$377K
CRNX icon
352
Crinetics Pharmaceuticals
CRNX
$8.95B
$1.03M 0.07%
34,563
+16,327
+90% +$336K
DLB icon
353
Dolby
DLB
$5.75B
$1.02M 0.07%
12,865
+4,147
+48% +$348K
EBF icon
354
Ennis
EBF
$560M
$1.02M 0.06%
47,880
+7,011
+17% +$149K
HOLX
355
DELISTED
Hologic
HOLX
$1.02M 0.06%
14,626
+8,089
+124% +$611K
FDX icon
356
FedEx
FDX
$76.3B
$1.01M 0.06%
3,829
-13
-0.3% -$3.38K
CMU
357
DELISTED
MFS High Yield Municipal Trust
CMU
$1M 0.06%
+320,191
New +$1.05M
UFPT icon
358
UFP Technologies
UFPT
$2.49B
$996K 0.06%
6,170
-20
-0.3% -$3.5K
RGNX icon
359
Regenxbio
RGNX
$703M
$994K 0.06%
60,364
-5,425
-8% -$98.3K
WBA
360
DELISTED
Walgreens Boots Alliance
WBA
$991K 0.06%
44,577
+2,143
+5% +$57K
EMR icon
361
Emerson Electric
EMR
$91.7B
$984K 0.06%
10,187
-5,919
-37% -$564K
MRTX
362
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$982K 0.06%
22,536
+1,284
+6% +$45.8K
EFT
363
Eaton Vance Floating-Rate Income Trust
EFT
$288M
$981K 0.06%
79,720
+21,090
+36% +$255K
ETSY icon
364
Etsy
ETSY
$7.29B
$977K 0.06%
15,132
-2,484
-14% -$196K
WRB icon
365
W.R. Berkley
WRB
$26B
$976K 0.06%
23,070
-462
-2% -$19.1K
KNSA icon
366
Kiniksa Pharmaceuticals
KNSA
$6.07B
$956K 0.06%
55,047
+26,002
+90% +$438K
OII icon
367
Oceaneering
OII
$5.05B
$949K 0.06%
+36,885
New +$842K
FT
368
Franklin Universal Trust
FT
$198M
$946K 0.06%
148,961
-39,732
-21% -$269K
GGG icon
369
Graco
GGG
$13.5B
$942K 0.06%
12,924
+4,199
+48% +$332K
ORLY icon
370
O'Reilly Automotive
ORLY
$74.9B
$940K 0.06%
15,510
+345
+2% +$21.6K
BF.B icon
371
Brown-Forman Class B
BF.B
$12.9B
$937K 0.06%
16,250
+355
+2% +$23.6K
NBW
372
DELISTED
Neuberger Berman California Municipal Fund Inc.
NBW
$937K 0.06%
95,681
-22,862
-19% -$240K
MQT
373
DELISTED
BlackRock MuniYield Quality Fund II
MQT
$936K 0.06%
104,123
-287,446
-73% -$2.82M
PKG icon
374
Packaging Corp of America
PKG
$22.9B
$929K 0.06%
6,047
-6,249
-51% -$912K
CXE
375
DELISTED
MFS High Income Municipal Trust
CXE
$925K 0.06%
+296,410
New +$1.01M

Similar funds

Hennion & Walsh Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Hennion & Walsh Asset Management held 854 positions worth $1.57B, down 7% from $1.69B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Hennion & Walsh Asset Management's Q3 2023 filing shows 57 new, 321 increased, 405 reduced and 55 closed positions. Its largest new stake was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M. The largest sale was Schwab US Dividend Equity ETF, an estimated $20.5M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Financials and Technology.

  • Hennion & Walsh Asset Management's largest Q3 2023 buy was WisdomTree Trust WisdomTree US SmallCap Quality Dividend Growth Fund: 474,056 shares worth $19.5M.
  • Hennion & Walsh Asset Management added most to Nuveen Municipal Credit Income Fund in Q3 2023, an estimated $2.51M increase.
  • Hennion & Walsh Asset Management's biggest Q3 2023 reduction was Schwab US Dividend Equity ETF, cutting an estimated $20.5M.
  • Hennion & Walsh Asset Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $4.42M.
  • Hennion & Walsh Asset Management's ten largest holdings make up 18% of its $1.57B portfolio in Q3 2023.
  • Hennion & Walsh Asset Management opened 57 new positions and closed 55 in Q3 2023.
  • Hennion & Walsh Asset Management's portfolio value fell 7% quarter-over-quarter to $1.57B.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2023, filed 27 Oct 2023.